Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Infusion Flow Rates and Blood Sampling

NCT: NCT02021617 · COMPLETED

NCT IDNCT02021617
StatusCOMPLETED
Start Date2013-11-05
Completion2013-11-15
SponsorVidacare Corporation (INDUSTRY)
First posted
Last updated

Brief Summary

* To evaluate infusion flow rates attainable when using the proximal humerus and proximal tibia IO vascular access sites. * To evaluate the intraosseous infusion physiology when using the proximal humerus and proximal tibia IO infusion sites. * To further evaluate the relationship between IO and venous blood when used for laboratory testing. * To determine the time from IO needle insertion to IO access established.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑